AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all patients with CLL require therapy. Despite all recent advances, the iwCLL still suggests watchful observation for sufferers with asymptomatic sickness.86 This suggestion is based on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both trial